SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME
CRME 2.330-2.1%May 16 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (220)11/26/2007 5:01:51 PM
From: Ian@SI   of 285
 
More speculation that COM/CRME may be taken out within the next 3 months was reported a little earlier this afternoon on BNN.

I didn't catch the analyst's name or company (Sounded like Ghati or Bhati neither of which are familiar to me as Biotech Analysts. I've just got to quit doing 2 things at once.)

Analyst believes that COM will have an easy time with the FDA getting V (oral) approved; that takeout will happen in less than 3 months and that it will be by big pharma.

Doesn't sound logical to me. Oral V's data will still be blinded; specifying both the company and the time for a takeover is not something that most analysts attempt.

And the stock price certainly hasn't behaved as if a takeover was imminent.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News